34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03826940 (ClinicalTrials.gov)	February 19, 2019	23/1/2019	From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1	Linking Inhibition From Molecular to Systems and Cognitive Levels: a Preclinical and Clinical Approa ...	Autism Spectrum Disorder;Neurofibromatosis 1	Drug: Lovastatin 60 MG;Drug: Placebos	University of Coimbra	NULL	Completed	16 Years	65 Years	All	16	N/A	Portugal
2	EUCTR2016-005022-10-DE (EUCTR)	13/02/2018	09/11/2017	Improvement of synaptic plasticity and cognitive function in RAS pathway disorders	Improvement of synaptic plasticity and cognitive function in RAS pathway disorders	Noonan Syndrom and Neurofibromatosis Type 1 MedDRA version: 20.0;Level: PT;Classification code 10029 ...	Product Name: Lovastatin INN or Proposed INN: Lovastatin Other descriptive name: LOVASTATIN Product Nam ...	Technische Universität München, Fakultät für Medizin	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 2	Germany
3	NCT00352599 (ClinicalTrials.gov)	September 2009	13/7/2006	Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)	Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)	Neurofibromatosis 1	Drug: Lovastatin;Drug: placebo pill	University of California, Los Angeles	NULL	Completed	10 Years	50 Years	Both	44	Phase 1	United States
4	NCT00853580 (ClinicalTrials.gov)	July 2009	23/2/2009	A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1	A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1	Neurofibromatosis Type 1	Drug: Lovastatin ™;Device: placebo	University of Alabama at Birmingham	Boston Children's Hospital;Children's Hospital of Philadelphia;Children's National Research Institut ...	Completed	8 Years	15 Years	All	146	Phase 2	United States;Australia

First Previous1Next Last